On July 6, 2021 and Aug 31, 2021, patents titled 鈥淧redicting response to immunotherapy using computer extracted features of cancer nuclei from hematoxylin and eosin (HandE) stained images of non-small cell lung cancer (NSCLC)鈥� and 鈥淪equential integration of adversarial networks with handcrafted features (SANwicH): identifying sites of prognostic significance for predicting cancer recurrence鈥� were awarded to CCIPD.
Article Date
August 31, 2021